Cyhoeddiadau
von Herrath M, Bain S, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR (2021) Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo controlled, phase 2 trial. The Lancet. In press
Williams DM, Ruslan AM, Khan R, Vijayasingam D, Iqbal F, Shaikh A, Lim J, Chudleigh R, Peter R, Udiawar M, Bain S, Stephens J, Min T (2021) Real-world clinical experience of semaglutide in secondary care diabetes: A retrospective observational study. Diabetes Therapy. doi.org/10.1007/s13300-021-01015-z
Bain S, Czernichow S, Bøgelund M, Madsen ME, Yssing C, McMillan AC, Hvid C, Hettiarachchige N, Panton UH (2021) Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model. Current Medical Research and Opinion. doi:10.1111/cob.12442
Chowdhury TA, Wahba M, Mallik R, Peracha J, Patel D, De P, Fogarty D, Frankel A, Karalliedde J, Mark PB, Montero RM, Pokrajac A, Varghese SZ, Bain S, Dasgupta I, Banerjee D, Winocour P, Sharif A (2021) Association of british clinical diabetologists and renal association guidelines on the detection and management of diabetes post solid organ transplantation. Diabetic Medicine. doi.org/10.1111/dme.14523
McCarthy O, Deere R, Eckstein ML, Pitt J, Wellman B, Bain S, Moser O, Bracken R (2020) Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals with Type 1 Diabetes. Frontiers in Public Health. doi.org/10.3389/fpubh.2020.568832
Persson F, Bain S, Mosenzon O, Heerspink HJL, Mann JFE, Pratley R, Raz I, Idorn T, Rasmussen S, von Scholten BJ, Rossing P (on behalf of the LEADER Trial Investigators) (2021) Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial. Diabetes Care. doi.org/10.2337/dc20-1622
Min T, Bain S (2021) The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials. Diabetes Therapy. doi.org/10.1007/s13300-020-00981-0
McCarthy O, Pitt J, Churm R, Dunseath G, Jones C, Bally L, Nakas CT, Deere R, Eckstein M, Bain S, Moser O, Bracken R (2020) Metabolomic, hormonal and physiological responses to hypoglycemia versus euglycemia during exercise in adults with type 1 diabetes. BMJ Open Diabetes Research & Care. 10.1136/bmjdrc-2020-001577
Husain M, Bain S, Holst AG, Mark T, Rasmussen S, Lingvay I (2020) Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials. Cardiovascular Diabetology. doi.org/10.1186/s12933-020-01106-4